S&P 500   2,715.33 (+1.94%)
DOW   23,156.75 (+2.10%)
QQQ   199.43 (+1.50%)
AAPL   263.11 (+0.24%)
FB   170.58 (+3.04%)
MSFT   166.49 (+0.74%)
GOOGL   1,197.35 (+1.20%)
CGC   14.75 (+2.86%)
NVDA   265.68 (-1.01%)
BABA   199.41 (+1.51%)
MU   47.55 (+2.54%)
GE   7.24 (+0.00%)
TSLA   552.19 (+6.96%)
AMD   49.00 (+3.11%)
T   30.48 (+3.53%)
ACB   0.82 (+2.50%)
F   4.84 (+6.84%)
NFLX   376.42 (-0.93%)
BAC   22.49 (+5.14%)
GILD   74.75 (-3.83%)
DIS   102.74 (+3.17%)
S&P 500   2,715.33 (+1.94%)
DOW   23,156.75 (+2.10%)
QQQ   199.43 (+1.50%)
AAPL   263.11 (+0.24%)
FB   170.58 (+3.04%)
MSFT   166.49 (+0.74%)
GOOGL   1,197.35 (+1.20%)
CGC   14.75 (+2.86%)
NVDA   265.68 (-1.01%)
BABA   199.41 (+1.51%)
MU   47.55 (+2.54%)
GE   7.24 (+0.00%)
TSLA   552.19 (+6.96%)
AMD   49.00 (+3.11%)
T   30.48 (+3.53%)
ACB   0.82 (+2.50%)
F   4.84 (+6.84%)
NFLX   376.42 (-0.93%)
BAC   22.49 (+5.14%)
GILD   74.75 (-3.83%)
DIS   102.74 (+3.17%)
S&P 500   2,715.33 (+1.94%)
DOW   23,156.75 (+2.10%)
QQQ   199.43 (+1.50%)
AAPL   263.11 (+0.24%)
FB   170.58 (+3.04%)
MSFT   166.49 (+0.74%)
GOOGL   1,197.35 (+1.20%)
CGC   14.75 (+2.86%)
NVDA   265.68 (-1.01%)
BABA   199.41 (+1.51%)
MU   47.55 (+2.54%)
GE   7.24 (+0.00%)
TSLA   552.19 (+6.96%)
AMD   49.00 (+3.11%)
T   30.48 (+3.53%)
ACB   0.82 (+2.50%)
F   4.84 (+6.84%)
NFLX   376.42 (-0.93%)
BAC   22.49 (+5.14%)
GILD   74.75 (-3.83%)
DIS   102.74 (+3.17%)
S&P 500   2,715.33 (+1.94%)
DOW   23,156.75 (+2.10%)
QQQ   199.43 (+1.50%)
AAPL   263.11 (+0.24%)
FB   170.58 (+3.04%)
MSFT   166.49 (+0.74%)
GOOGL   1,197.35 (+1.20%)
CGC   14.75 (+2.86%)
NVDA   265.68 (-1.01%)
BABA   199.41 (+1.51%)
MU   47.55 (+2.54%)
GE   7.24 (+0.00%)
TSLA   552.19 (+6.96%)
AMD   49.00 (+3.11%)
T   30.48 (+3.53%)
ACB   0.82 (+2.50%)
F   4.84 (+6.84%)
NFLX   376.42 (-0.93%)
BAC   22.49 (+5.14%)
GILD   74.75 (-3.83%)
DIS   102.74 (+3.17%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Esperion TherapeuticsBELLUS HealthArvinasAkcea TherapeuticsAimmune Therapeutics
SymbolNASDAQ:ESPROTCMKTS:BLUSFNASDAQ:ARVNNASDAQ:AKCANASDAQ:AIMT
Price Information
Current Price$34.03N/A$42.98$15.92$15.08
52 Week RangeBuyN/ABuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$87.33N/A$50.80$34.67$43.45
% Upside from Price Target156.64% upsideN/A18.19% upside117.76% upside188.26% upside
Trade Information
Market Cap$878.67 million$1.47 billion$1.65 billion$1.47 billion$837.26 million
Beta2.21.552.281.330.92
Average Volume1,006,17561,933420,547314,8832,016,860
Sales & Book Value
Annual Revenue$148.36 million$30,000.00$42.98 million$488.54 millionN/A
Price / Sales6.310.0039.083.29N/A
CashflowN/AN/AN/A$0.56 per shareN/A
Price / CashN/AN/AN/A28.51N/A
Book Value$0.73 per share$0.25 per share$6.72 per share$5.78 per share$1.66 per share
Price / Book46.620.006.402.75N/A
Profitability
Net Income$-97,170,000.00$-7,010,000.00$-70,290,000.00$40.77 million$-248,500,000.00
EPS($3.59)N/A($2.13)$0.48($3.97)
Trailing P/E RatioN/A0.00N/A34.61N/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-65.49%-49,910.34%-163.56%8.35%N/A
Return on Equity (ROE)-98.94%-48.37%-30.16%10.03%-138.44%
Return on Assets (ROA)-38.29%-45.25%-20.99%8.70%-90.72%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.06%N/A0.02%0.03%0.50%
Current Ratio3.20%13.87%8.86%11.83%3.14%
Quick Ratio3.20%13.87%8.86%11.62%3.14%
Ownership Information
Institutional Ownership PercentageN/AN/A77.22%20.65%74.69%
Insider Ownership Percentage7.70%24.17%31.77%1.50%13.75%
Miscellaneous
Employees761083248228
Shares Outstanding27.51 million159.12 million39.08 million101.07 million62.67 million
Next Earnings Date5/13/2020 (Estimated)N/A5/13/2020 (Estimated)5/13/2020 (Estimated)5/13/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel